Ask AI
ProCE Banner Activity

Expert Commentary on the Use of IL-13 Inhibition in Treating Moderate to Severe Atopic Dermatitis

Clinical Thought

In this commentary, Dr Jonathan Silverberg provides insights on incorporating IL-13 inhibitors into the treatment algorithm for moderate to severe atopic dermatitis.

Released: May 19, 2023

Continue Activity View Activity

Share

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly